Clinical trial
OPtimal Medical Strategy for Patients With Acute Coronary Syndrome Treated With Drug-eluting Stents: Enhancing Outcomes With antiPlatelet and Lipid-lowering Therapy (OPACT Trial)
NCT07432516 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- OPtimal Medical Strategy for Patients With Acute Coronary Syndrome Treated With Drug-eluting Stents: Enhancing Outcomes With antiPlatelet and Lipid-lowering Therapy (OPACT Trial)
- Lead sponsor
- Yonsei University
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- February 28, 2026
- Completion date
- June 30, 2033
- Enrollment
- 4,400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.